Safety and efficacy of a novel abluminal groove‐filled biodegradable polymer sirolimus‐eluting stent for the treatment of de novo coronary lesions: Two‐year results from a prospective patient‐level pooled analysis of TARGET trials

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. S1, 2015-03 ,pp. : 734-743

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the tryton bifurcation stent in conjunction with an everolimus‐eluting stent: IUVANT (Intravascular ultrasound evaluation of tryton stent) study

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 4, 2015-03 ,pp. : 544-553

John Wiley & Sons Inc

Access to resources Recommend Favorite

First report of a novel polymer‐free dual‐drug eluting stent in de novo coronary artery disease: Results of the first in human BICARE trial

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 83, Iss. 3, 2014-02 ,pp. : 405-411

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease

By Zhang Feng   Dong Lili   Qian Juying   Ge Junbo  

Annals of Medicine, Vol. 43, Iss. 1, 2011-02 ,pp. : 75-79

Informa Healthcare

Access to resources Recommend Favorite

Assessment of a Drug-Eluting Balloon for the Treatment of de novo Coronary Lesions Guided by Optical Coherence Tomography: Study Protocol for a Randomized Controlled Trial

By  

Cardiology, Vol. 136, Iss. 4, 2016-11 ,pp. : 252-257

Karger

Access to resources Recommend Favorite